PHAXIAM Therapeutics
A biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
Enterprise value
$15m
Share price
$0.54 ERYP
Company register number
479560013
Recent deals
Authorizing premium user...